PEDIATRIC RHEUMATOLOGY, ISSN 1546-0096, 05/2017, Volume 15, Issue S1, pp. 105 - 201
Journal Article
Arthritis Care & Research, ISSN 2151-464X, 11/2010, Volume 62, Issue 11, pp. 1542 - 1551
Objective To assess health‐related quality of life (HRQOL) in abatacept‐treated children/adolescents with juvenile idiopathic arthritis (JIA). Methods In this...
RHEUMATOID-ARTHRITIS | EFFICACY | SAFETY | COSTIMULATION MODULATOR ABATACEPT | PHASE IIB | DISEASE | DOUBLE-BLIND | METHOTREXATE | PLACEBO-CONTROLLED TRIAL | RHEUMATOLOGY | CHILDREN | Double-Blind Method | Humans | Male | Arthritis, Juvenile - drug therapy | Arthritis, Juvenile - physiopathology | Pain - psychology | Abatacept | Pain - drug therapy | Pain - physiopathology | Adolescent | Immunoconjugates - therapeutic use | Sleep Stages - physiology | Arthritis, Juvenile - psychology | Female | Surveys and Questionnaires | Quality of Life - psychology | Health Status | Child
RHEUMATOID-ARTHRITIS | EFFICACY | SAFETY | COSTIMULATION MODULATOR ABATACEPT | PHASE IIB | DISEASE | DOUBLE-BLIND | METHOTREXATE | PLACEBO-CONTROLLED TRIAL | RHEUMATOLOGY | CHILDREN | Double-Blind Method | Humans | Male | Arthritis, Juvenile - drug therapy | Arthritis, Juvenile - physiopathology | Pain - psychology | Abatacept | Pain - drug therapy | Pain - physiopathology | Adolescent | Immunoconjugates - therapeutic use | Sleep Stages - physiology | Arthritis, Juvenile - psychology | Female | Surveys and Questionnaires | Quality of Life - psychology | Health Status | Child
Journal Article
College & Research Libraries, ISSN 0010-0870, 04/2017, Volume 77, Issue 6
Understanding perceptions of Library and Information Science (LIS) students on two dimensions—belief in the importance (BIM) of a set of core information...
Journal Article
Arthritis Care & Research, ISSN 2151-464X, 11/2010, Volume 62, Issue 11, pp. 1533 - 1541
Objective To develop a provisional definition for the evaluation of response to therapy in juvenile dermatomyositis (DM) based on the Paediatric Rheumatology...
SYSTEMIC-LUPUS-ERYTHEMATOSUS | OUTCOME ASSESSMENT | MYOSITIS ASSESSMENT SCALE | PRELIMINARY CORE SET | CLINICAL-TRIALS | IMPROVEMENT | IDIOPATHIC INFLAMMATORY MYOPATHIES | PRELIMINARY DEFINITION | DAMAGE INDEXES | RHEUMATOLOGY | VALIDATED DISEASE-ACTIVITY | Reproducibility of Results | Humans | Dermatomyositis - epidemiology | Child, Preschool | Male | Treatment Outcome | Dermatomyositis - therapy | Rheumatology - standards | Internationality | Female | Pediatrics - standards | Clinical Trials as Topic - standards | Child | consensus | disease activity | core set | response to therapy | juvenile dermatomyositis
SYSTEMIC-LUPUS-ERYTHEMATOSUS | OUTCOME ASSESSMENT | MYOSITIS ASSESSMENT SCALE | PRELIMINARY CORE SET | CLINICAL-TRIALS | IMPROVEMENT | IDIOPATHIC INFLAMMATORY MYOPATHIES | PRELIMINARY DEFINITION | DAMAGE INDEXES | RHEUMATOLOGY | VALIDATED DISEASE-ACTIVITY | Reproducibility of Results | Humans | Dermatomyositis - epidemiology | Child, Preschool | Male | Treatment Outcome | Dermatomyositis - therapy | Rheumatology - standards | Internationality | Female | Pediatrics - standards | Clinical Trials as Topic - standards | Child | consensus | disease activity | core set | response to therapy | juvenile dermatomyositis
Journal Article
Materials Science & Engineering C, ISSN 0928-4931, 09/2017, Volume 78, pp. 1231 - 1245
Sensor technology for the rapid detection of the analytes with high sensitivity and selectivity has several challenges. Despite the challenges, colorimetric...
Metal nanoparticles | Biosensor | Interference | Sensor | Colorimetric | GOLD NANOPARTICLES | BACTERIA | MATERIALS SCIENCE, BIOMATERIALS | ARRAY | ASSAY | VISUAL DETECTION | MELAMINE | COPPER IONS | IMMUNOSENSOR | AGGREGATION | Surface Plasmon Resonance | Gold | Colorimetry | Silicon Dioxide | Metal Nanoparticles | Biological products | Sensors | Index Medicus
Metal nanoparticles | Biosensor | Interference | Sensor | Colorimetric | GOLD NANOPARTICLES | BACTERIA | MATERIALS SCIENCE, BIOMATERIALS | ARRAY | ASSAY | VISUAL DETECTION | MELAMINE | COPPER IONS | IMMUNOSENSOR | AGGREGATION | Surface Plasmon Resonance | Gold | Colorimetry | Silicon Dioxide | Metal Nanoparticles | Biological products | Sensors | Index Medicus
Journal Article
Pediatric Rheumatology Online Journal, 05/2017, Volume 15, Issue S1, pp. 1 - 104
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2018, Volume 77, Issue Suppl 2, p. 501
ObjectivesTo develop, validate and implement a transition readiness assessment tool to be completed by adolescents living with juvenile idiopathic...
Adolescence | Motivation | Personal health | Cognitive ability | Questionnaires | Arthritis | Teenagers | Inflammation | Children | Patients | Emotions
Adolescence | Motivation | Personal health | Cognitive ability | Questionnaires | Arthritis | Teenagers | Inflammation | Children | Patients | Emotions
Journal Article
JAMA, ISSN 0098-7484, 04/2010, Volume 303, Issue 13, pp. 1266 - 1273
CONTEXT Novel therapies have improved the remission rate in chronic inflammatory disorders including juvenile idiopathic arthritis (JIA). Therefore, strategies...
RHEUMATOID-ARTHRITIS | CRITERIA | THERAPY | PROTEINS 8 | INFLAMMATION | VALIDATION | SELECT CATEGORIES | UMCG Approved | DISCONTINUATION | DISEASE-ACTIVITY | CHILDREN | MEDICINE, GENERAL & INTERNAL | Predictive Value of Tests | Recurrence | Calgranulin B - blood | Prospective Studies | Antirheumatic Agents - administration & dosage | Humans | Child, Preschool | Infant | Male | Remission Induction | Arthritis, Juvenile - drug therapy | ATP-Binding Cassette Transporters - blood | Adolescent | Female | Methotrexate - administration & dosage | Child | Clinical trials | Biomarkers | Patient safety | Arthritis | Drug therapy | Risk factors
RHEUMATOID-ARTHRITIS | CRITERIA | THERAPY | PROTEINS 8 | INFLAMMATION | VALIDATION | SELECT CATEGORIES | UMCG Approved | DISCONTINUATION | DISEASE-ACTIVITY | CHILDREN | MEDICINE, GENERAL & INTERNAL | Predictive Value of Tests | Recurrence | Calgranulin B - blood | Prospective Studies | Antirheumatic Agents - administration & dosage | Humans | Child, Preschool | Infant | Male | Remission Induction | Arthritis, Juvenile - drug therapy | ATP-Binding Cassette Transporters - blood | Adolescent | Female | Methotrexate - administration & dosage | Child | Clinical trials | Biomarkers | Patient safety | Arthritis | Drug therapy | Risk factors
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2018, Volume 77, Issue Suppl 2, p. 219
BackgroundShared decision making (SDM) is an emerging trend in paediatrics. Currently available SDM interventions are mere information on the disease or...
Cost-benefit analysis | Decision making | Arthritis | Inflammation | Children | Patients | Quality of life
Cost-benefit analysis | Decision making | Arthritis | Inflammation | Children | Patients | Quality of life
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2018, Volume 77, Issue Suppl 2, p. 102
BackgroundEfficacy and safety of intravenous (IV) tocilizumab (TCZ) were demonstrated in patients (pts) with systemic juvenile idiopathic arthritis (sJIA) in...
Pharmacodynamics | Intravenous administration | Antiinflammatory agents | C-reactive protein | Glucocorticoids | Body weight | Arthritis | Inflammation | E.S.R | Sedimentation | Patients | Cough | Interleukin 6 | Respiratory tract diseases | Children | Safety | Pharmacokinetics | Neutropenia
Pharmacodynamics | Intravenous administration | Antiinflammatory agents | C-reactive protein | Glucocorticoids | Body weight | Arthritis | Inflammation | E.S.R | Sedimentation | Patients | Cough | Interleukin 6 | Respiratory tract diseases | Children | Safety | Pharmacokinetics | Neutropenia
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2018, Volume 77, Issue Suppl 2, p. 215
BackgroundAt present no clear evidence based guidelines exist to standardise the tapering and discontinuation of corticosteroids (CS) in juvenile...
Corticoids | Intravenous administration | MMT | Dermatomyositis | Remission | Prednisone | Children | Methylprednisolone
Corticoids | Intravenous administration | MMT | Dermatomyositis | Remission | Prednisone | Children | Methylprednisolone
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 05/2019, Volume 21, Issue 1, pp. 125 - 10
BackgroundTo describe the 6-year safety and efficacy of etanercept (ETN) in children with extended oligoarticular juvenile idiopathic arthritis (eoJIA),...
Psoriatic arthritis (PsA) | Etanercept | Extended oligoarticular juvenile idiopathic arthritis (eoJIA) | Enthesitis-related arthritis (ERA) | Clinical trial | Efficacy | Safety | Enthesitis-related arthritis | Juvenile idiopathic arthritis | ADALIMUMAB | INITIATION | METHOTREXATE | RHEUMATOLOGY | CATEGORIES | DISEASE-ACTIVITY | CHILDREN | NECROSIS-FACTOR | PEDIATRIC-PATIENTS | DOUBLE-BLIND | DEFINING CRITERIA | Dosage and administration | Drug therapy | Patient outcomes | Juvenile arthritis | Psoriatic arthritis | Pediatrics | Back pain | Rheumatology | Tumor necrosis factor-TNF | TNF inhibitors | Arthritis | Patients | Drug dosages
Psoriatic arthritis (PsA) | Etanercept | Extended oligoarticular juvenile idiopathic arthritis (eoJIA) | Enthesitis-related arthritis (ERA) | Clinical trial | Efficacy | Safety | Enthesitis-related arthritis | Juvenile idiopathic arthritis | ADALIMUMAB | INITIATION | METHOTREXATE | RHEUMATOLOGY | CATEGORIES | DISEASE-ACTIVITY | CHILDREN | NECROSIS-FACTOR | PEDIATRIC-PATIENTS | DOUBLE-BLIND | DEFINING CRITERIA | Dosage and administration | Drug therapy | Patient outcomes | Juvenile arthritis | Psoriatic arthritis | Pediatrics | Back pain | Rheumatology | Tumor necrosis factor-TNF | TNF inhibitors | Arthritis | Patients | Drug dosages
Journal Article
Arthritis research & therapy, ISSN 1478-6354, 12/2018, Volume 20, Issue 1, pp. 285 - 11
BACKGROUND: The availability of methotrexate and the introduction of multiple biological agents have revolutionized the treatment of juvenile idiopathic...
Adverse events | Biologics | Registry | Safety | Methotrexate | Journal Article | Juvenile idiopathic arthritis | RHEUMATOID-ARTHRITIS | VALIDATION | RHEUMATOLOGY | CHILDREN | MALIGNANCY | ALPHA BLOCKERS | ITALIAN INCEPTION COHORTS | GERMAN BIOLOGICS | QUALITY-OF-LIFE | ETANERCEPT | TERM HEALTH OUTCOMES | Usage | Pharmacology, Experimental | Antirheumatic agents | Rheumatoid arthritis in children | Drug therapy | Political aspects | Statistics | Biopharmaceutics | Drugs | Pediatrics | Bacterial infections | Tuberculosis | Disease | Rheumatology | Data collection | TNF inhibitors | Tumor necrosis factor-TNF | Infections | Arthritis
Adverse events | Biologics | Registry | Safety | Methotrexate | Journal Article | Juvenile idiopathic arthritis | RHEUMATOID-ARTHRITIS | VALIDATION | RHEUMATOLOGY | CHILDREN | MALIGNANCY | ALPHA BLOCKERS | ITALIAN INCEPTION COHORTS | GERMAN BIOLOGICS | QUALITY-OF-LIFE | ETANERCEPT | TERM HEALTH OUTCOMES | Usage | Pharmacology, Experimental | Antirheumatic agents | Rheumatoid arthritis in children | Drug therapy | Political aspects | Statistics | Biopharmaceutics | Drugs | Pediatrics | Bacterial infections | Tuberculosis | Disease | Rheumatology | Data collection | TNF inhibitors | Tumor necrosis factor-TNF | Infections | Arthritis
Journal Article
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 2017, Volume 12, Issue 1, pp. 167 - 41
BACKGROUND: Hereditary recurrent fevers (HRF) are a group of rare monogenic diseases leading to recurrent inflammatory flares. A large number of variants has...
Traps | MKD | Hereditary recurrent fevers | Infevers | Genotype-phenotype associations | Caps | FMF | Eurofever | MEDICINE, RESEARCH & EXPERIMENTAL | FAMILIAL MEDITERRANEAN FEVER | GENE | GENETICS & HEREDITY | PERIODIC FEVERS | MUTATIONS | Genetic aspects | Research | Hereditary autoinflammatory diseases | Risk factors | Genes | Gangrene | Tumor necrosis factor-TNF | Mutation | Patients | Fever | Chronic illnesses
Traps | MKD | Hereditary recurrent fevers | Infevers | Genotype-phenotype associations | Caps | FMF | Eurofever | MEDICINE, RESEARCH & EXPERIMENTAL | FAMILIAL MEDITERRANEAN FEVER | GENE | GENETICS & HEREDITY | PERIODIC FEVERS | MUTATIONS | Genetic aspects | Research | Hereditary autoinflammatory diseases | Risk factors | Genes | Gangrene | Tumor necrosis factor-TNF | Mutation | Patients | Fever | Chronic illnesses
Journal Article
Pediatric Rheumatology, ISSN 1546-0096, 12/2017, Volume 15, Issue 1, pp. 86 - 10
Background: Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatic disease and a leading cause of childhood disability. The objective of...
Dosing | Tofacitinib | Safety | Pharmacokinetics | Pediatric | Janus kinase inhibitor | Juvenile idiopathic arthritis | PLACEBO | METHOTREXATE | PREVALENCE | RHEUMATOLOGY | CP-690,550 | TRIAL | OF-RHEUMATOLOGY RECOMMENDATIONS | PEDIATRICS | EPIDEMIOLOGY | Protein Kinase Inhibitors - pharmacokinetics | Piperidines - administration & dosage | Pyrroles - pharmacokinetics | Administration, Oral | Pyrimidines - administration & dosage | Humans | Child, Preschool | Male | Treatment Outcome | Protein Kinase Inhibitors - adverse effects | Arthritis, Juvenile - drug therapy | Protein Kinase Inhibitors - administration & dosage | Pyrroles - administration & dosage | Piperidines - adverse effects | Adolescent | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Pyrroles - adverse effects | Female | Piperidines - pharmacokinetics | Taste | Child | Treatment outcome | Safety and security measures | Patient outcomes | Analysis | Rheumatoid arthritis in children | Dosage and administration | Research | Drug therapy | Pediatric research
Dosing | Tofacitinib | Safety | Pharmacokinetics | Pediatric | Janus kinase inhibitor | Juvenile idiopathic arthritis | PLACEBO | METHOTREXATE | PREVALENCE | RHEUMATOLOGY | CP-690,550 | TRIAL | OF-RHEUMATOLOGY RECOMMENDATIONS | PEDIATRICS | EPIDEMIOLOGY | Protein Kinase Inhibitors - pharmacokinetics | Piperidines - administration & dosage | Pyrroles - pharmacokinetics | Administration, Oral | Pyrimidines - administration & dosage | Humans | Child, Preschool | Male | Treatment Outcome | Protein Kinase Inhibitors - adverse effects | Arthritis, Juvenile - drug therapy | Protein Kinase Inhibitors - administration & dosage | Pyrroles - administration & dosage | Piperidines - adverse effects | Adolescent | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Pyrroles - adverse effects | Female | Piperidines - pharmacokinetics | Taste | Child | Treatment outcome | Safety and security measures | Patient outcomes | Analysis | Rheumatoid arthritis in children | Dosage and administration | Research | Drug therapy | Pediatric research
Journal Article
Pediatric Rheumatology, ISSN 1546-0096, 05/2019, Volume 17, Issue 1, pp. 24 - 11
BackgroundPrednisone (PDN) in juvenile dermatomyositis (JDM), alone or in association with other immunosuppressive drugs, namely methotrexate (MTX) and...
Prednisone tapering | Juvenile dermatomyositis | Core set measures | Disease activity | Glucorticoids | ACTIVITY SCORE | POLYMYOSITIS | IDIOPATHIC INFLAMMATORY MYOPATHIES | ADULT DERMATOMYOSITIS | RHEUMATOLOGY | CLINICALLY INACTIVE DISEASE | MYOSITIS ASSESSMENT | RHEUMATOLOGY RESEARCH ALLIANCE | HEALTH QUESTIONNAIRE CHQ | PLUS METHOTREXATE | CHILDHOOD ARTHRITIS | PEDIATRICS | Corticosteroids | Dermatomyositis | Dosage and administration | Research | Drug therapy | Pediatric research | Evidence-based medicine
Prednisone tapering | Juvenile dermatomyositis | Core set measures | Disease activity | Glucorticoids | ACTIVITY SCORE | POLYMYOSITIS | IDIOPATHIC INFLAMMATORY MYOPATHIES | ADULT DERMATOMYOSITIS | RHEUMATOLOGY | CLINICALLY INACTIVE DISEASE | MYOSITIS ASSESSMENT | RHEUMATOLOGY RESEARCH ALLIANCE | HEALTH QUESTIONNAIRE CHQ | PLUS METHOTREXATE | CHILDHOOD ARTHRITIS | PEDIATRICS | Corticosteroids | Dermatomyositis | Dosage and administration | Research | Drug therapy | Pediatric research | Evidence-based medicine
Journal Article